Evidence map›Paper›PMID 21295283›Full record

ArticleAmerican journal of human genetics2011

Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa.

Stephan Züchner, Julia Dallman, Rong Wen, Gary Beecham, Adam Naj, Amjad Farooq, Martin A Kohli, Patrice L Whitehead, William Hulme, Ioanna Konidari and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 172 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. DHDDS and NUS1: A Converging Pathway and Common Phenotype.Movement disorders clinical practice · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Vertebrate Animal Models of RP59: Current Status and Future Prospects.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Knockdown of Dehydrodolichyl Diphosphate Synthase in theFrontiers in molecular neuroscience · 2021
    Article
  19. Article
  20. Structural elucidation of theProceedings of the National Academy of Sciences of the United States of America · 2020
    Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 3 institutions in 1 country.

Stephan ZüchnerJohn P. Hussman Institute for Human Genomics, University of Miami Miller School of Medicine, Miami, FL 33136, USA.
Julia Dallman
Rong Wen
Gary Beecham
Adam Naj
Amjad Farooq
Martin A Kohli
Patrice L Whitehead
William Hulme
Ioanna Konidari
Yvonne J K Edwards
Guiqing Cai
Inga Peter
David Seo
Joseph D Buxbaum
Jonathan L Haines
Susan Blanton
Juan Young
Eduardo Alfonso
Jeffery M Vance
Byron L Lam
Margaret A Peričak-Vance
University of Miami · USIcahn School of Medicine at Mount Sinai · USVanderbilt University · US

Funding

trainingU54NS065712 · NINDS · WAYNE STATE UNIVERSITY · PI SHY, MICHAEL E. · 2009 to 2023
$19.6M
Unifying Genetics Epidemiology of Macular DegenerationR01EY012118 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI AGARWAL, ANITA, HAINES, JONATHAN L · 2006 to 2015
$12.2M
Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Structural and Functional Studies of the Novel DBD Domain of MKP5R01GM083897 · NIGMS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI FAROOQ, AMJAD · 2008 to 2012
$1.6M
CNTF and retinal degeneration: the role of Muller cellsR01EY018586 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI WEN, RONG · 2008 to 2011
$1.5M
NEI NIH HHS P30 EY014801NEI NIH HHS P30-EY14801NEI NIH HHS R01 EY012118NEI NIH HHS R01-EY012118NEI NIH HHS R01 EY018586NEI NIH HHS R01-EY018586NIGMS NIH HHS R01 GM083897NIGMS NIH HHS R01-GM083897NINDS NIH HHS U54 NS065712NINDS NIH HHS U54-NS065712
6 · The paper itself

Abstract

Increasingly, mutations in genes causing Mendelian disease will be supported by individual and small families only; however, exome sequencing studies have thus far focused on syndromic phenotypes characterized by low locus heterogeneity. In contrast, retinitis pigmentosa (RP) is caused by >50 known genes, which still explain only half of the clinical cases. In a single, one-generation, nonsyndromic RP family, we have identified a gene, dehydrodolichol diphosphate synthase (DHDDS), demonstrating the power of combining whole-exome sequencing with rapid in vivo studies. DHDDS is a highly conserved essential enzyme for dolichol synthesis, permitting global N-linked glycosylation. Zebrafish studies showed virtually identical photoreceptor defects as observed with N-linked glycosylation-interfering mutations in the light-sensing protein rhodopsin. The identified Lys42Glu variant likely arose from an ancestral founder, because eight of the nine identified alleles in 27,174 control chromosomes were of confirmed Ashkenazi Jewish ethnicity. These findings demonstrate the power of exome sequencing linked to functional studies when faced with challenging study designs and, importantly, link RP to the pathways of N-linked glycosylation, which promise new avenues for therapeutic interventions.

Indexed as

Alkyl and Aryl TransferasesAnimalsDolicholsExonsFemaleGenes, DominantGenetic VariationGlycosylationHumansMaleMutationPedigreePhenotypePolymerase Chain ReactionRetinitis PigmentosaRhodopsinAlkyl and Aryl Transferasesdehydrodolicholdehydrodolichyl diphosphate synthetaseDolicholsRhodopsinZebrafish Proteins

Identifiers

PMID21295283
PMCPMC3035708
OpenAlexW2153282442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.